Add BrightSurf on Google Email

Making tumors more responsive to immunotherapy

Researchers have discovered how reprogrammed cancer cells can promote the formation of immune cells clusters that help coordinate the immune response, leading to better treatment outcomes for patients. The study's findings suggest that cell reprogramming could become a way to make tumors more responsive to immunotherapy.

SourceLund University·JournalImmunity·TypeExperimental study·DateNov 6, 2026

Study reveals distinct cellular and genetic differences in colorectal cancer in younger patients

Researchers identified age-associated differences in tumor composition and gene activity in younger patients with colorectal cancer, including a higher proportion of connective cells and long non-coding RNAs. These differences may contribute to chemotherapy resistance and increased cancer aggression in younger adults.

SourceMass General Brigham·JournalNature Medicine·TypeExperimental study·DateOct 29, 2026

Intraoperative dorsal lung ventilation reduction and postoperative pulmonary complications

A recent study found that a greater reduction in dorsal lung ventilation is independently associated with postoperative pulmonary complications in laparoscopic colorectal cancer surgery. Patients with a reduction of dorsal lung ventilation ≥14.5% had a higher incidence of postoperative pulmonary complications.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeData/statistical analysis·DateOct 28, 2026

Rising rates of colorectal cancer found in nearly all age groups

A new study published in NEJM Evidence found that colorectal cancer rates are rising across younger and older age groups, with younger adults now at the highest risk. The study found that the age-adjusted incidence rate fell in the early 2000s but rose to 38.3 in 2023, with the sharpest increase among 45-49-year-olds. The researchers w...

SourceUniversity of Chicago Medical Center·JournalNEJM Evidence·TypeData/statistical analysis·DateOct 27, 2026

International tumor board explores personalized treatment strategies for colon cancer without measurable disease

The case report highlights the challenges of monitoring residual disease in stage IIIc colon cancer, where conventional imaging shows no measurable tumor but circulating tumor DNA and DNA methylation patterns suggest molecular residual disease. Molecular profiling and international collaboration may help guide treatment decisions in su...

SourceImpact Journals LLC·JournalOncotarget·TypeCase study·DateOct 26, 2026

New study finds metastatic colorectal cancer’s immune defenses may begin outside the cancer cell, challenging view held for decades

Researchers identified a molecular pathway that offers a new target for treatment, challenging a 30-year-old theory in cancer research. The study found that immune defenses may begin outside the cancer cell, creating an environment that prevents the immune system from attacking the cancer.

SourceUniversity of South Florida·JournalJournal of Experimental & Clinical Cancer Research·TypeData/statistical analysis·DateOct 14, 2026

Metastatic colorectal cancer is more advanced in younger patients than older ones, but they survive longer with the disease, study finds

A retrospective cohort study of 50,802 patients with metastatic colorectal cancer found that younger patients (aged 45 and younger) had longer median disease-specific survival and a higher rate of 10-year survival compared to older patients. Younger patients were also more likely to have tumors in the left-sided colon and rectum, and a...

‘Invisible’ inflammation in rare bowel disease may explain heightened colon cancer risk

Researchers have mapped cellular differences between two similar bowel diseases, identifying hidden immune activity that may explain why one carries a much higher risk of colon cancer. The study found that patients with PSC-associated IBD had a distinct microbiome and higher levels of immune activity even in the absence of inflammation.

SourceGarvan Institute of Medical Research·JournalNature Communications·TypeObservational study·DateSep 21, 2026

Not all colonoscopies are the same. New AI audits them at scale

A new AI tool has been developed to rapidly and accurately measure colonoscopy quality, improving care quality and reducing colorectal cancer mortality. The tool analyzed nearly 19,000 colonoscopies performed by 55 physicians, identifying key moments and tracking quality indicators that cannot be feasibly measured by humans at scale.

SourceNorthwestern University·JournalThe American Journal of Gastroenterology·DateSep 8, 2026

Major study reveals key differences in bowel cancer before 50

Researchers analyzed data from 1,691 Australians with liver-spreading bowel cancer, finding younger patients had distinct tumour characteristics and lived longer after treatment. Genetic mutations such as BRAF and KRAS were associated with poorer outcomes across both age groups, highlighting the importance of genetic testing.

SourceFlinders University·JournalThe Medical Journal of Australia·TypeMeta-analysis·DateAug 31, 2026

A single blood sample may improve the prediction of colorectal cancer recurrence or metastasis, kaist study finds

A joint KAIST research team developed a new framework for analyzing networks of circulating amino acids, reflecting the body's metabolic state. They showed that this approach can predict recurrence or metastasis in patients with colorectal cancer more accurately than current methods.

SourceThe Korea Advanced Institute of Science and Technology (KAIST)·JournalAdvanced Science·TypeObservational study·DateJul 21, 2026

Researchers analyzing colon cancer screenings find hope for higher retest rates

A Rutgers-led study of nearly 500,000 adults reveals that repeat testing is linked to earlier diagnoses and depends on primary care provider behaviors. The study found that health systems play a significant role in increasing patient consistency, with Kaiser Permanente having the highest adherence rate.

SourceRutgers University·JournalClinical Gastroenterology and Hepatology·TypeObservational study·DateJul 19, 2026

Study reveals why some colorectal cancers respond better to immunotherapy

A subset of cancers, known as microsatellite instability (MSI) and deficient DNA mismatch repair (dMMR) cancers, are more visible to the immune system than others. Researchers from the Keck School of Medicine of USC identified a biological feedback loop that helps activate the immune response against these types of cancer.

SourceKeck School of Medicine of USC·JournalGastroenterology·TypeExperimental study·DateJul 16, 2026

Cellular recycling protein plays critical protective role in the gut

Researchers at Olivia Newton-John Cancer Research Institute discovered that reduced BECLIN1 levels weaken the gut's protective barrier, leading to increased susceptibility to inflammation and disease. This finding may help explain why some people are more susceptible to gut inflammation and associated diseases.

SourceOlivia Newton-John Cancer Research Institute·JournalCell Death and Disease·TypeExperimental study·DateJul 12, 2026

Fasting primes gut microbiome to improve intestinal recovery after radiation treatment

A new preclinical study has identified a gut bacterium, Akkermansia muciniphila, that helps prime intestinal stem cells for faster recovery after radiation treatment. Fasting increases the population of this bacterium, which produces a small molecule that changes histone tags to allow gene expression in intestinal cells.

SourceUniversity of Texas M. D. Anderson Cancer Center·JournalProceedings of the National Academy of Sciences·DateJul 9, 2026